MRPL41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.541800E-01
Normal-vs-Stage2
5.128000E-01
Normal-vs-Stage3
7.172000E-01
Normal-vs-Stage4
6.595800E-01
Stage1-vs-Stage2
9.425400E-01
Stage1-vs-Stage3
2.515400E-01
Stage1-vs-Stage4
7.080800E-01
Stage2-vs-Stage3
2.605400E-01
Stage2-vs-Stage4
7.146600E-01
Stage3-vs-Stage4
4.973800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.572400E-01
Normal-vs-AfricanAmerican
6.187000E-01
Normal-vs-Asian
3.687600E-02
Caucasian-vs-AfricanAmerican
1.367420E-01
Caucasian-vs-Asian
9.950400E-02
AfricanAmerican-vs-Asian
2.380200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.476400E-01
Normal-vs-Female
5.450400E-01
Male-vs-Female
1.399400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.996400E-01
Normal-vs-Age(41-60Yrs)
4.503800E-01
Normal-vs-Age(61-80Yrs)
5.323000E-01
Normal-vs-Age(81-100Yrs)
2.897600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.093200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.314000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.445400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.770200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.329400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.808800E-01
Normal-vs-Daily Drinker
2.239200E-01
Normal-vs-Weekly Drinker
2.323800E-02
Normal-vs-Occasional Drinker
4.703200E-01
Normal-vs-Social Drinker
4.139800E-01
Non Drinker-vs-Daily Drinker
6.562300E-02
Non Drinker-vs-Weekly Drinker
7.626400E-02
Non Drinker-vs-Occasional Drinker
5.850000E-01
Non Drinker-vs-Social Drinker
5.137200E-01
Daily Drinker-vs-Weekly Drinker
3.905600E-01
Daily Drinker-vs-Occasional Drinker
3.259800E-01
Daily Drinker-vs-Social Drinker
3.836000E-01
Weekly Drinker-vs-Occasional Drinker
1.519980E-01
Weekly Drinker-vs-Social Drinker
1.688180E-01
Occasional Drinker-vs-Social Drinker
9.336000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.919000E-01
Normal-vs-Grade 2
8.404400E-01
Normal-vs-Grade 3
9.844600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.807200E-01
Grade 1-vs-Grade 3
3.161800E-01
Grade 1-vs-Grade 4
7.919000E-01
Grade 2-vs-Grade 3
3.691000E-01
Grade 2-vs-Grade 4
8.404400E-01
Grade 3-vs-Grade 4
9.844600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.135200E-01
Normal-vs-NonDiabetic
3.685000E-01
Diabetic-vs-NonDiabetic
5.391400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.491240E-01
Normal-vs-NoPancreatitis
4.126600E-01
Pancreatitis-vs-NoPancreatitis
2.296200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.383000E-01
Normal-vs-N1
5.730200E-01
N0-vs-N1
2.473800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.644200E-01
Normal-vs-TP53-NonMutant
7.150400E-01
TP53-Mutant-vs-TP53-NonMutant
7.371000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
